International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8088525
Original Article
Comparison of Central Corneal Thickness and Endothelial Cell Count Following Small Incision Cataract Surgery Between Immature and Mature Cataracts
 ,
 ,
 ,
Published
June 28, 2023
Abstract

Background: This study aimed to compare changes in central corneal thickness (CCT) and endothelial cell count following small incision cataract surgery between immature and mature cataracts.

Methods: A hospital-based observational study was conducted on 60 patients (51.7% male, 48.3% female) who underwent manual small incision cataract surgery. The study population comprised 30 immature and 30 mature cataract patients. The patients were evaluated preoperatively and on days 1, 1 week, 6 weeks, and 12 weeks postoperatively.

Results: Postoperative CCT increased on day 1 (immature: 544.33µm, mature: 555.43µm) and then gradually decreased to near preoperative levels by the 6th week (immature: 494.9µm, mature: 495.83µm). The immature cataract group exhibited a higher mean preoperative endothelial cell count (2574.03 cells/mm²) than the mature group (2447.46 cells/mm²). Although both groups experienced a decrease in endothelial cell count, the immature group maintained a higher count throughout the postoperative period, reaching 2276.23 cells/mm² by the 3rd month, compared to 2072.43 cells/mm² in the mature group. Visual acuity showed significant improvement postoperatively, with 96.7% of immature and 90% of mature cataract patients achieving a visual acuity of 6/6 to 6/18 at the 6th week.

Conclusion: Small incision cataract surgery has a minimal long-term impact on corneal thickness and results in a manageable decrease in endothelial cell count in both immature and mature cataracts.

Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
1963 Views
139 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved